FDA May Introduce Warnings for COVID-19 Vaccines

The U.S. Food and Drug Administration (FDA) is reportedly planning to add “black box” warnings—its most serious safety alert—to COVID-19 vaccines, possibly by the year’s end. This information comes from a recent report that points to rising concerns about vaccine safety.

It’s interesting to note that the FDA operates under the Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy. The Commissioner of the FDA answers directly to him, which adds another layer of oversight to this process.

If future reports hold true, these warnings could outline serious risks associated with the COVID-19 vaccines, like myocarditis or unexpected sudden death. However, the specifics of this plan aren’t finalized yet, and the FDA hasn’t made an official statement on any upcoming changes.

A memo from the FDA, dated late November, revealed that an analysis of pediatric deaths reported to the Vaccine Adverse Event Reporting System (VAERS) between 2021 and 2024 indicated at least 10 deaths of children linked to mRNA vaccines, primarily due to myocarditis. This conclusion came from Dr. Vinay Prasad, the chief medical officer at the FDA, after a detailed review.

Still, many health professionals contest these warnings as being unwarranted.

A black box warning, notably displayed in a bold black box on a medication’s prescribing information, serves to alert healthcare providers about serious risks that should be carefully considered alongside the vaccine’s benefits. Similar warnings can be found on opioids for abuse and overdose risks, while other drugs, like Accutane, warn about potential birth defects during pregnancy.

This information was shared by two sources familiar with the FDA’s ongoing discussions regarding the black box warning for COVID-19 vaccines. Dr. Prasad appears to be spearheading this initiative, but it’s important to note that the plans remain tentative and lack official confirmation.

It isn’t clear whether these warnings would apply solely to mRNA vaccines or extend to all COVID-19 vaccines and specific demographics. An unnamed source mentioned that all pertinent information should be available by year’s end.

The FDA has approved three vaccines for use in the U.S.; of those, the Pfizer and Moderna options utilize mRNA technology, which seems to be the focus of the impending warning.

HHS spokesperson Andrew Nixon stated that, “unless the FDA makes an announcement, any claims about their future actions are purely speculative.”

Former President Donald Trump has been vocal about his concerns regarding childhood vaccinations. In September, he suggested a staggered vaccination schedule for vaccines like MMR (measles, mumps, rubella), arguing against the current practice.

“Vaccines are very interesting,” Trump commented. He acknowledged their benefits but expressed hesitance about overwhelming infants with too many vaccines at once. “It’s common sense too… It can be scary.”

Dr. Aaron Kesselheim, a professor at Harvard University, pointed out that typically, black box warnings follow thorough investigations by either the manufacturer or the FDA, including public advisory committee reviews. In this case, however, he noted, it seems those procedures haven’t been adhered to.

“I’m concerned that there is no due process outlined here. This feels rushed,” Kesselheim said in an interview, suggesting that such a significant decision lacks the backed scientific review normally expected for a serious health determination.